Evidence map›Paper›PMID 26393648›Full record

ReviewNutrients2015

Lactose Intolerance in Adults: Biological Mechanism and Dietary Management.

Yanyong Deng, Benjamin Misselwitz, Ning Dai, Mark Fox

Open access · goldAbstract readReview
In one paragraph

Review in Nutrients, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 99 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
99citing papers in PubMed, 4 pooled it
20.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

99 citing papers in PubMed, 4 syntheses or guidelines pooled it, 342 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Pooled it
  4. Guideline
  5. Trial
  6. Trial
  7. Observational
  8. Article
  9. Review
  10. Review
  11. Effects ofMicroorganisms · 2026
    Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article

39 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Yanyong DengDepartment of Gastroenterology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, 3 East Qingchun Road, 310016 Hangzhou, China. dengyanyong@163.com.
Benjamin MisselwitzNeurogastroenterology and Motility Research Group, Department of Gastroenterology and Hepatology, Division of Gastroenterology & Hepatology, University Hospital Zürich, Zürich CH-8091, Switzerland. benjamin.misselwitz@usz.ch.
Ning DaiDepartment of Gastroenterology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, 3 East Qingchun Road, 310016 Hangzhou, China. ndaicn@yahoo.com.
Mark FoxNeurogastroenterology and Motility Research Group, Department of Gastroenterology and Hepatology, Division of Gastroenterology & Hepatology, University Hospital Zürich, Zürich CH-8091, Switzerland. dr.mark.fox@gmail.com.
Sir Run Run Shaw Hospital · CNSt. Claraspital · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lactose intolerance related to primary or secondary lactase deficiency is characterized by abdominal pain and distension, borborygmi, flatus, and diarrhea induced by lactose in dairy products. The biological mechanism and lactose malabsorption is established and several investigations are available, including genetic, endoscopic and physiological tests. Lactose intolerance depends not only on the expression of lactase but also on the dose of lactose, intestinal flora, gastrointestinal motility, small intestinal bacterial overgrowth and sensitivity of the gastrointestinal tract to the generation of gas and other fermentation products of lactose digestion. Treatment of lactose intolerance can include lactose-reduced diet and enzyme replacement. This is effective if symptoms are only related to dairy products; however, lactose intolerance can be part of a wider intolerance to variably absorbed, fermentable oligo-, di-, monosaccharides and polyols (FODMAPs). This is present in at least half of patients with irritable bowel syndrome (IBS) and this group requires not only restriction of lactose intake but also a low FODMAP diet to improve gastrointestinal complaints. The long-term effects of a dairy-free, low FODMAPs diet on nutritional health and the fecal microbiome are not well defined. This review summarizes recent advances in our understanding of the genetic basis, biological mechanism, diagnosis and dietary management of lactose intolerance.

Indexed as

Diet, Carbohydrate-RestrictedGastrointestinal TractAdultDairy ProductsDigestionFermentationGastrointestinal AbsorptionGastrointestinal MicrobiomeGenetic Predisposition to DiseaseHumansLactaseLactoseLactose IntolerancePhenotypePredictive Value of TestsRisk FactorsLactaseLactoseFODMAPgenetic testhydrogen breath testirritable bowel syndromelactase deficiencylactose intolerancelactose malabsorption

Identifiers

PMID26393648
PMCPMC4586575
OpenAlexW1946152840

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.